|
|
|
Volumn 5, Issue 6, 2001, Pages 564-568
|
|
A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy
a
|
|
Author keywords
Anti tuberculosis drugs; Congenital abnormality; Pregnancy
|
|
Indexed keywords
CYCLOSERINE;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
PROTIONAMIDE;
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ARTICLE;
CARDIOVASCULAR MALFORMATION;
CASE CONTROL STUDY;
CONGENITAL MALFORMATION;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG USE;
EAR MALFORMATION;
ENVIRONMENTAL EXPOSURE;
FEMALE;
GESTATIONAL AGE;
HUMAN;
HUNGARY;
HYPOSPADIAS;
LIMB DEFECT;
MAJOR CLINICAL STUDY;
MALE;
NEURAL TUBE DEFECT;
NEWBORN;
POLYDACTYLY;
PREGNANCY;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
REGISTER;
RISK FACTOR;
SYNDACTYLY;
TERATOGENICITY;
TUBERCULOSIS;
ABNORMALITIES, DRUG-INDUCED;
ADMINISTRATION, ORAL;
ANTITUBERCULAR AGENTS;
CASE-CONTROL STUDIES;
FEMALE;
FETAL DISEASES;
HUMANS;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
ISONIAZID;
MALE;
MATERNAL EXPOSURE;
ODDS RATIO;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTER, SECOND;
PREGNANCY TRIMESTER, THIRD;
|
|
EID: 0034963048
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (36)
|
|
References (12)
|
